Effect of beta-blocker therapy on progression of aortic dilatation in the Marfan syndrome patients with subtypes of fibrillin 1 gene mutation

ConclusionWith beta-blocker therapy, the rate of aortic dilatation for FBN1-MFS patients was delayed and not significantly different between subtypes of FBN1 gene mutation.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research